Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN)

Goldberg H., Miller R. C., Abdah-Bortnyak R., Steiner M., YILDIZ F., Meirovitz A., ...Daha Fazla

GYNECOLOGIC ONCOLOGY, cilt.108, sa.2, ss.298-305, 2008 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 108 Sayı: 2
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1016/j.ygyno.2007.10.037
  • Dergi Adı: GYNECOLOGIC ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.298-305
  • Anahtar Kelimeler: chemotherapy, radiation therapy, surgery, uterine papillary serous carcinoma, STAGE-I PATIENTS, CHEMOTHERAPY, RADIOTHERAPY, MANAGEMENT, RADIATION, SURVIVAL, ENDOMETRIUM, DOXORUBICIN, CISPLATIN
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Objectives. Uterine papillary serous carcinoma (UPSC) is a rare subtype of endometrial carcinoma, characterized by a poor outcome. We sought to better analyze the effect of surgery and adjuvant therapies on this disease.